Need immediate assistance? Call 1-518-730-0559 (Us-Canada Toll Free) or Contact Us

 

Assisted Reproductive Technology Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017 – 2025

Table of Content

1. Preface
     1.1. Market Definition and Scope
     1.2. Market Segmentation
     1.3. Key Research Objectives
     1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Assisted Reproductive Technology Market 

4. Market Overview
     4.1. Introduction
     4.2. Overview
     4.3. Key Market Indicators
     4.4. Market Dynamics
            4.4.1. Drivers
            4.4.2. Restraints
            4.4.3. Opportunity
     4.5. Global Assisted Reproductive Technology Market  Analysis and Forecasts, 2015–2025
            4.5.1. Market Revenue Projections (US$ Mn)
     4.6. Assisted Reproductive Technology Market  - Global Supply Demand Scenario
     4.7. Porter’s Five Force Analysis
     4.8. Market Outlook
     4.9. Assisted Reproductive Technology: Regional Funding Scenario
     4.10. In Vitro Fertilization Costs, by Region, 2016
     4.11. Assisted Reproductive Technology: Indication

5. Global Assisted Reproductive Technology Market  Analysis and Forecasts, By Technology
     5.1. Introduction & Definition
     5.2. Key Findings / Developments
     5.3. Key Trends
     5.4. Market Value Forecast By Technology, 2015–2025
            5.4.1. In Vitro Fertilization
                     5.4.1.1. Intra-cytoplasmic Sperm Injection (ICSI) 
                     5.4.1.2 .Preimplantation Genetic Diagnosis (PGD)
            5.4.2. Artificial Insemination
                     5.4.2.1. Intrauterine Insemination (IUI)
                     5.4.2.2. Intracervical Insemination (ICI)
                     5.4.2.3. Others
            5.4.3. Surrogacy
            5.4.4. Others
     5.5. Market Attractiveness By Technology

6. Global Assisted Reproductive Technology Market  Analysis and Forecasts, By Procedure 
     6.1. Introduction & Definition
     6.2. Key Findings / Developments
     6.3. Key Trends
     6.4. Market Value Forecast By Procedure, 2015–2025
            6.4.1. Frozen Donor
            6.4.2. Frozen Non Donor
            6.4.3. Fresh Donor
            6.4.4. Fresh Non Donor
            6.4.5. Embryo Banking
     6.5. Market Attractiveness By Procedure 

7. Global Assisted Reproductive Technology Market  Analysis and Forecasts, By End User 
     7.1. Introduction & Definition
     7.2. Key Findings / Developments
     7.3. Key Trends
     7.4. Market Value Forecast By End User, 2015–2025
            7.4.1. Fertility Clinics 
            7.4.2. Hospitals
            7.4.3. Others
     7.5. Market Attractiveness By End User 

8. Global Assisted Reproductive Technology Market  Analysis and Forecasts, By Region
     8.1. Key Findings
     8.2. Policies and Regulations
     8.3. Market Value Forecast By Region
            8.3.1. North America 
            8.3.2. Europe 
            8.3.3. Asia Pacific 
            8.3.4. Latin America 
            8.3.5. Middle East and Africa 
     8.4. Market Attractiveness By Country/Region

9. North America Assisted Reproductive Technology Market  Analysis and Forecast
     9.1. Introduction
            9.1.1. Key Findings
            9.1.2. Policies and Regulations
            9.1.3. Key Trends
     9.2. Market Value Forecast By Technology , 2015–2025
            9.2.1. In Vitro Fertilization
                     9.2.1.1. Intra-cytoplasmic Sperm Injection (ICSI) 
                     9.2.1.2. Preimplantation Genetic Diagnosis (PGD)
           9.2.2. Artificial Insemination
                     9.2.2.1. Intrauterine Insemination (IUI)
                     9.2.2.2. Intracervical Insemination (ICI)
                     9.2.2.3. Others
            9.2.3. Surrogacy
            9.2.4. Others
     9.3. Market Value Forecast By Procedure , 2015–2025
            9.3.1. Frozen Donor
            9.3.2. Frozen Non Donor
            9.3.3. Fresh Donor
            9.3.4. Fresh Non Donor
            9.3.5. Embryo Banking
     9.4. Market Value Forecast By End User , 2015–2025
            9.4.1. Fertility Clinics 
            9.4.2. Hospitals
            9.4.3. Others
     9.5. Market Value Forecast By Country , 2015–2025
            9.5.1. U.S.
            9.5.2. Canada
     9.6. Market Attractiveness Analysis 
            9.6.1. By Technology
            9.6.2. By Procedure 
            9.6.3. By End User 
            9.6.4. By Country

10. Europe Assisted Reproductive Technology Market  Analysis and Forecast
     10.1.Introduction
            10.1.1. Key Findings
            10.1.2. Policies and Regulations
            10.1.3. Key Trends
     10.2.Market Value Forecast By Technology , 2015–2025
            10.2.1. In Vitro Fertilization
                     10.2.1.1. Intra-cytoplasmic Sperm Injection (ICSI) 
                     10.2.1.2. Preimplantation Genetic Diagnosis (PGD)
            10.2.2. Artificial Insemination
                     10.2.2.1. Intrauterine Insemination (IUI)
                     10.2.2.2. Intracervical Insemination (ICI)
                     10.2.2.3. Others
            10.2.3. Surrogacy
            10.2.4. Others
     10.3.Market Value Forecast By Procedure , 2015–2025
            10.3.1. Frozen Donor
            10.3.2. Frozen Non Donor
            10.3.3. Fresh Donor
            10.3.4. Fresh Non Donor
            10.3.5. Embryo Banking
     10.4.Market Value Forecast By End User , 2015–2025
            10.4.1. Fertility Clinics 
            10.4.2. Hospitals
            10.4.3. Others
     10.5.Market Value Forecast By Country , 2015–2025
            10.5.1. Germany
            10.5.2. France
            10.5.3. U.K.
            10.5.4. Spain
            10.5.5. Italy
            10.5.6. Russia
            10.5.7. Rest of Europe
     10.6.Market Attractiveness Analysis 
            10.6.1. By Technology
            10.6.2. By Procedure 
            10.6.3. By End User 
            10.6.4. By Country

11. Asia Pacific Assisted Reproductive Technology Market  Analysis and Forecast
     11.1.Introduction
            11.1.1. Key Findings
            11.1.2. Policies and Regulations
            11.1.3. Key Trends
     11.2.Market Value Forecast By Technology, 2015–2025
            11.2.1. In Vitro Fertilization
                     11.2.1.1.Intra-cytoplasmic Sperm Injection (ICSI) 
                     11.2.1.2.Preimplantation Genetic Diagnosis (PGD)
            11.2.2. Artificial Insemination
                     11.2.2.1.Intrauterine Insemination (IUI)
                     11.2.2.2.Intracervical Insemination (ICI)
                     11.2.2.3.Others
            11.2.3. Surrogacy
            11.2.4. Others
     11.3.Market Value Forecast By Procedure, 2015–2025
            11.3.1. Frozen Donor
            11.3.2. Frozen Non Donor
            11.3.3. Fresh Donor
            11.3.4. Fresh Non Donor
            11.3.5. Embryo Banking
     11.4.Market Value Forecast By End User, 2015–2025
            11.4.1. Fertility Clinics 
            11.4.2. Hospitals
            11.4.3. Others
     11.5.Market Value Forecast By Country, 2015–2025
            11.5.1. China
            11.5.2. Japan
            11.5.3. India
            11.5.4. Australia & New Zealand
            11.5.5. Rest of Asia Pacific
     11.6.Market Attractiveness Analysis 
            11.6.1. By Technology
            11.6.2. By Procedure 
            11.6.3. By End User 
            11.6.4. By Country

12. Latin America Assisted Reproductive Technology Market  Analysis and Forecast
     12.1.Introduction
            12.1.1. Key Findings
            12.1.2. Policies and Regulations
            12.1.3. Key Trends
     12.2.Market Value Forecast By Technology , 2015–2025
            12.2.1. In Vitro Fertilization
                     12.2.1.1. Intra-cytoplasmic Sperm Injection (ICSI) 
                     12.2.1.2. Preimplantation Genetic Diagnosis (PGD)
            12.2.2. Artificial Insemination
                     12.2.2.1. Intrauterine Insemination (IUI)
                     12.2.2.2. Intracervical Insemination (ICI)
                     12.2.2.3. Others
            12.2.3. Surrogacy
            12.2.4. Others
     12.3.Market Value Forecast By Procedure , 2015–2025
            12.3.1. Frozen Donor
            12.3.2. Frozen Non Donor
            12.3.3. Fresh Donor
            12.3.4. Fresh Non Donor
            12.3.5. Embryo Banking
     12.4.Market Value Forecast By End User , 2015–2025
            12.4.1. Fertility Clinics 
            12.4.2. Hospitals
            12.4.3. Others
     12.5.Market Value Forecast By Country , 2015–2025
            12.5.1. Brazil
            12.5.2. Mexico
            12.5.3. Rest of Latin America
     12.6.Market Attractiveness Analysis 
            12.6.1. By Technology
            12.6.2. By Procedure 
            12.6.3. By End User 
            12.6.4. By Country

13. Middle East and Africa Assisted Reproductive Technology Market  Analysis and Forecast
     13.1.Introduction
            13.1.1. Key Findings
            13.1.2. Policies and Regulations
            13.1.3. Key Trends
     13.2.Market Value Forecast By Technology , 2015–2025
            13.2.1. In Vitro Fertilization
                     13.2.1.1. Intra-cytoplasmic Sperm Injection (ICSI) 
                     13.2.1.2. Preimplantation Genetic Diagnosis (PGD)
            13.2.2. Artificial Insemination
                     13.2.2.1. Intrauterine Insemination (IUI)
                     13.2.2.2. Intracervical Insemination (ICI)
                     13.2.2.3. Others
            13.2.3. Surrogacy
            13.2.4. Others
     13.3.Market Value Forecast By Procedure , 2015–2025
            13.3.1. Frozen Donor
            13.3.2. Frozen Non Donor
            13.3.3. Fresh Donor
            13.3.4. Fresh Non Donor
            13.3.5. Embryo Banking
     13.4.Market Value Forecast By End User , 2015–2025
            13.4.1. Fertility Clinics 
            13.4.2. Hospitals
            13.4.3. Others
     13.5.Market Value Forecast By Country , 2015–2025
            13.5.1. GCC Countries
            13.5.2. South Africa
            13.5.3. Rest of Middle East and Africa
     13.6.Market Attractiveness Analysis 
            13.6.1. By Technology
            13.6.2. By Procedure 
            13.6.3. By End User 
            13.6.4. By Country

14. Competition Landscape
     14.1.Market Player – Competition Matrix (By Tier and Size of companies)
     14.2.Market Share Analysis By Company (2016)
     14.3. ART Service Providers: Market Snapshot
     14.4.Company Profiles 
            14.4.1. Merck KGaA
                     14.4.1.1 Overview
                     14.4.1.2 Financials
                     14.4.1.3.Recent Developments
                     14.4.1.4 Strategy
            14.4.2. CooperSurgical, Inc.
                     14.4.2.1 Overview
                     14.4.2.2 Financials
                     14.4.2.3.Recent Developments
                     14.4.2.4. Strategy
            14.4.3. Irvine Scientific.
                     14.4.3.1 Overview
                     14.4.3.2 Financials
                     14.4.3.3.Recent Developments
                     14.4.3.4. Strategy
            14.4.4. Vitrolife AB.
                     14.4.4.1 Overview
                     14.4.4.2 Financials
                     14.4.4.3.Recent Developments
                     14.4.4.4. Strategy
            14.4.5. Hamilton Thorne, Inc.
                     14.4.5.1 Overview
                     14.4.5.2 Financials
                     14.4.5.3.Recent Developments
                     14.4.5.4. Strategy
            14.4.6. Nikon Corporation 
                     14.4.6.1 Overview
                     14.4.6.2 Financials
                     14.4.6.3.Recent Developments
                     14.4.6.4. Strategy
            14.4.7 Nidacon International AB 
                     14.4.7.1 Overview
                     14.4.7.2 Financials
                     14.4.7.3.Recent Developments
                     14.4.7.4. Strategy
            14.4.8. Laboratoire CCD 
                     14.4.8.1 Overview
                     14.4.8.2 Financials
                     14.4.8.3.Recent Developments
                     14.4.8.4. Strategy
            14.4.9. Planer PLC 
                     14.4.9.1 Overview
                     14.4.9.2 Financials
                     14.4.9.3.Recent Developments
                     14.4.9.4. Strategy
            14.4.10. Esco Micro Pte. Ltd. (Esco Group)
                     14.4.10.1 Overview
                     14.4.10.2 Financials
                     14.4.10.3.Recent Developments
                     14.4.10.4. Strategy

Custom Market Research Services

MRRSE offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Get A Free Custom Research Quote